ORAMED PHARMACEUTICALS INC. reports

Company location: New York, NY
Fiscal year end: 31 December

ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 126-150 of 773 matching filings.

Per page

25

Current page

6

8-K File 001-35813

CURRENT REPORT

Filing date: 23 Jan 2024
Reporting date: 22 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 19 Jan 2024
Reporting date: 17 Jan 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Jan 2024
Reporting date: 04 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 02 Jan 2024
Reporting date: 01 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 21 Dec 2023
Reporting date: 21 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 18 Dec 2023
Reporting date: 18 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-35813

QUARTERLY REPORT

Filing date: 09 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 26 Sep 2023
Reporting date: 21 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 13 Sep 2023
Reporting date: 11 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT DATED AUGUST 17, 2023

Filing date: 22 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-35813

QUARTERLY REPORT

Filing date: 10 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 09 Aug 2023
Reporting date: 07 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 07 Aug 2023
Reporting date: 04 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-35813

CURRENT REPORT

Filing date: 13 Jul 2023
Reporting date: 13 Jul 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-35813

FORM ARS

Filing date: 31 May 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-35813

DEFINITIVE PROXY STATEMENT

Filing date: 31 May 2023
Reporting date: 13 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 May 2023
Reporting date: 26 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .